Montevideo, Uruguay – April 7, 2026. – B4-RNA, a biotechnology company using its next-generation RNA sequencing technology platform to aid drug development, today announced a collaboration with Resolve Therapeutics. The collaboration will identify inflammatory RNA molecules circulating in the bloodstream of patients with autoimmune diseases that could become potential drug